BBC World Documentary about Liz Parrish’s effort to tackle aging as a disease

BBC World reporter Gabriela Torres has met Liz to learn about BioViva’s project to make cutting edge therapies, that have been proven safe in animals, available for humans in the near future at an affordable price. <br/> Source : BBC World

Read more

Slowly but surely is not always the best way to proceed

Liz Parrish warns against the consequences of excessive regulatory precautions. In our current world of exponential medical progress not taking risks can cause more deaths than being less risk averse. ““As a matter of fact, not intervening in one’s health is more reckless because we already know how we’ll...

Read more

Image

Liz Parrish Interview with Benjamin Stecher

“From diagnosing aging related dysfunctions, to predicting future ill health, preventing sickness using gene and cell therapies, and maintaining optimal health using advanced nutritional support — we deeply care about the health and well being of all, and using our clinics and our products we want to deliver personalized,...

Read more

Elizabeth Parrish

Liz Parrish in keynote interview at The Business of Longevity Conference in Hong Kong

On October 27th 2017 The Economist magazine held a conference on the economic impact of extreme Longevity, bringing together leading minds to discuss how society can make the transition to an older but still productive population. Our CEO, Liz Parrish was invited at this event for a keynote interview...

Read more

Liz Parrish to Harper’s Magazine: “This is not aesthetics – this is survival”.

“People need to understand that this is not aesthetics—this is survival.”

Read more

Liz Parrish Interviewed By BBC World Service Documentary ‘Forever Young’

BBC World Service interviews BioViva’s CEO Liz Parrish for ‘Forever Young’, a documentary on pioneers and self experimentation in the world of longevity. Liz explains why self experimentation and calculated risk taking has an important role in accelerating progress today, and why risk-avoidance is perhaps the riskiest behaviour of...

Read more

The Lowdown on Biohacking: It’s Time For An Upgrade

From fighting aging, to boosting athletic ability and tackling cancer, gene therapies are ushering in an exciting new era. Read all about the biohacking phenomenon as BioViva is mentioned in Outside’s latest feature on the growing Biohacking movement: ‘”In 2015, Liz Parrish, the CEO of the startup BioViva, announced...

Read more

Pioneering New Medicine: Bloomberg Interviews Liz Parrish

Globalive Chairman Anthony Lacavera interviews BioViva’s CEO Liz Parrish. Liz covers the pressing need for novel medical innovations to target the aging process, why BioViva’s gene therapy represents a smarter approach, and how a combination of regenerative therapies will drive the future of healthcare. Source: Bloomberg

Read more

Futurism: Therapies To Combat Aging Are Coming

A host of researchers and companies across the globe are beginning to develop and market treatments targeting the aging process for the first time. Catch a mention of BioViva’s work in the latest round up from Futurism.

Read more

No Image

Liz Parrish on Digital Health Today

Liz Parrish, CEO and Founder of BioViva, on Digital Health Today. Liz discusses the need for innovation solutions to aging and age-related disease, the importance of classifying aging as a disease, and BioViva’s work developing gene and cell therapies to prevent, delay and reverse biological aging.

Read more

No Image

Liz Parrish At L’Echappée Volée In Paris

Liz spoke at L’Echappée Volée in May about BioViva’s gene therapies and the need for innovative new solutions to the problem of aging and age-related disease. Catch a preview of the final talk which will be uploaded soon here. In this article Le Monde discusses the event, summarizing Liz’s...

Read more

The World of Tomorrow According to Liz Parrish

Last week, Liz Parrish, BioViva’s founder and CEO, sat down for a chat with the French publication .  During the interview Liz discussed about her vision of a world without suffering from disease, the technologies that will bring that world to fruition, and how BioViva will help.  Unfortunately, the interview...

Read more

No Image

Liz Parrish at Wired Health 2017: Aging is a Disease. Gene Therapy Could be the Cure

Our CEO, Liz Parrish, spoke at the Wired Health conference in London last month. At the conference Liz spoke about how her son being diagnosed with Type 1 Diabetes was the motivation behind her researching gene therapy treatments for cures. She also spoke about how and why she tested...

Read more

How Humans Are Shaping Our Own Evolution – And BioViva Is Leading The Way

BioViva and our CEO, Elizabeth Parrish, have been featured in the latest National Geographic article about the future of human evolution and how technology is accelerating it. We have chosen some of our favorite sections from the article but we recommend you read the whole thing. Please see the...

Read more

The Search To Extend Lifespan Is Gaining Ground… And Bioviva Is Creating The Optimal Solutions

“….using genetically engineered viruses to force old mice to make more telomerase results in a longer lifespan with improved late-life health, without an increased risk of cancer. Elizabeth Parrish, who is the CEO of BioViva – a company working to develop anti-aging treatments – recently travelled to Colombia to...

Read more

Gene Therapy: The Woman Who Views Aging As A Disease

Elizabeth Parrish is the founder and CEO of BioViva, a biotech company which advocates gene and cell therapies to treat the diseases of aging. She is a major advocate of patient access to these revolutionary treatments, and became a test subject in September 2015 after receiving treatment for what...

Read more

Our CEO Liz Parrish spoke at Wired Health 2017 about why: Aging is a disease. Gene therapy could be the ‘cure’

“She (Liz Parrish) had spent more than two years studying literature, talking to experts, and had decided to undergo gene therapy – a treatment for genetic disorders that adds genes into cells to replace those that are faulty or absent.” “I was a person who quite honestly felt I...

Read more

Liz Parrish – Gene Therapy to Treat the Diseases of Aging on NRK TV’s Trygdekontoret

Liz Parrish, CEO of BioViva, speaks about helping people live longer healthier lives by using gene and cell therapies. Liz was speaking at Norways NRK TV show Trygdekontoret.

Read more

WIRED Health 2017 London: Looking Into The Future of Healthcare

Last week WIRED Health gathered hundreds of leaders and influencers from across the globe in London to discuss the field of health innovation and technology. In addition to their long lists of honors and historic accolades, the unrivaled lineup of speakers brought an infectious enthusiasm for action in healthcare....

Read more

ABC Lateline: An Interview With Liz Parrish

Jeremy Fernandez speaks to Liz Parrish, the CEO of BioViva – an American biotech developing treatments to slow the ageing process in humans. ABC Australia

Read more

Becoming the First Transhuman: A Call For The Right Stuff

Who will officially be the first transhuman? Transhumanity  

Read more

Can this woman cure ageing with gene therapy?

Elizabeth Parrish is CEO of BioViva, a Seattle-based biotech company working to develop treatments to slow the ageing process. In April, the company revealed that Parrish herself had undergone “the first gene therapy successful against human ageing”. The treatment, it claimed, had reversed the biological age of her immune...

Read more

Did A Biotech CEO Reverse Her Own Aging Process?

According to BioViva and to interviews with its CEO, Elizabeth Parrish, Parrish received two therapies last year, one to protect against the loss of muscle mass, and one to lengthen her telomeres. Forbes

Read more

Gene doping in sport could make the Olympics fairer and safer

claims to have given herself two kinds of experimental gene therapy, one of which blocks the breakdown of muscle tissue. In other words, your muscles stay strong even if you don’t exercise – and grow faster if you do. New Scientist

Read more

Biotech execs in search of human guinea pigs find eager subjects: themselves

Liz Parrish, CEO of the biotech BioViva USA Inc., was injected last September with two of the company’s experimental gene therapies. STAT News

Read more

Liz Parrish Is Patient Zero in Her Own Anti-Aging Experiment

Elizabeth (Liz) Parrish is the CEO of BioViva, a biotechnology company that focuses on developing gene therapies, and other regenerative therapies, to intervene with human aging.Last September, Parrish added an interesting line to her job description: patient zero for two anti-aging therapies that the company is researching. Discover Magazine

Read more

First Data from Anti-Aging Gene Therapy

A biotech company reports that an experimental treatment elongated its CEO’s telomeres. The Scientist

Read more

Scientists Claim They’ve Completed the First Successful Gene Therapy Against Human Ageing

The CEO of Bioviva USA Inc, Elizabeth Parrish, claims to be the first human in world history to have successfully reversed the effects of natural ageing – thanks to experimental gene therapy provided by her company. Science Alert

Read more

Scientists Say They’ve Completed the First Ever Successful Gene Therapy to Combat Old Age

Elizabeth Parrish, the CEO of BioViva USA Inc, a biotechnology company that “aims to provide regenerative medicine to the masses through gene and cell therapies,” claims to be the first person in history to have successfully reversed one of the hallmark signs of aging with the company’s experimental gene...

Read more

Is Silicon Valley Birthing The Next Pro-Lifers?

Elizabeth Parrish is 44, the tough-gunning, sharp-talking CEO of a life-sciences startup, and seemingly full of life herself. But she says she suffers from a deadly disease. Hoping to stave off the sickness, Parrish recently journeyed to a clinic in Colombia, where she underwent a course of therapy that...

Read more

A Tale of Do-It-Yourself Gene Therapy

Can aging be slowed by using gene therapy to make permanent changes to a person’s DNA? MIT Technology Review

Read more

Human Gene Therapy Successfully Lengthens Telomeres

In a bold and courageous move Elizabeth Parrish, CEO of Bioviva USA inc. became the first human to be treated with two gene therapies that her company has developed, one to lengthen her telomeres and one to prevent aging-related loss in muscle mass. With this move, she follows the...

Read more

Anti-aging Gene Therapy: Has The Time Arrived For True Anti-aging Medicine?

Now in 2016 it is becoming increasingly clear that therapies are emerging which could seriously impact aspects of the human aging process. One of the most cutting-edge therapies that are now being tested is the use of viral vectors to lengthen telomeres, the DNA caps at the end of...

Read more

Promising Results From The First Human Gene Therapy Against Aging

The CEO of Bioviva USA Inc., Elizabeth Parrish, became the first person to undergo rejuvenative gene therapy in 2015, and results are now out – the procedure successfully lengthened her telomeres by the equivalent of 20 years.

Read more

First Gene Therapy Successful Against Human Aging

In September 2015, then 44 year-old CEO of BioViva USA Inc. Elizabeth Parrish received two of her own company’s experimental gene therapies: one to protect against loss of muscle mass with age, another to battle stem cell depletion responsible for diverse age-related diseases and infirmities. The treatment was originally...

Read more